PND49 An Assessment of Real-World Healthcare Provider Experiences with Insomnia Medications Focusing on Suvorexant in the United States (US)

This study evaluated healthcare provider (HCP) experiences with suvorexant and other pharmacotherapies (for example, benzodiazepines, non-benzodiazepines sleep agents such as zolpidem, eszopiclone, zaleplon, or antidepressants) in a real-world setting.

Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: M. Carlyle, Z. Qureshi, C. Martin, J. White, R. Khandker Source Type: research